Armando López-Guillermo

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

Julio Delgado, Alejandro Martín, Marcos González, 2017, British journal of haematology.

Next-generation sequencing in chronic lymphocytic leukemia.

Carlos López-Otín, A. López-Guillermo, E. Campo, 2013, Seminars in hematology.

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

Emili Montserrat, Beatriz Bellosillo, Dolors Colomer, 2003, The New England journal of medicine.

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

Manel Juan, Adrian Wiestner, Marta Aymerich, 2013, Proceedings of the National Academy of Sciences.

Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia

Alfonso Valencia, David Tamborero, Daniel Rico, 2014, Genome research.

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

Andrew Lister, Anne Sonet, Hervé Tilly, 2011, The Lancet.

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.

Emili Montserrat, Brunangelo Falini, Dolors Colomer, 2003, Blood.

Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia

Alfonso Valencia, Modesto Orozco, Brandy Klotzle, 2012, Nature Genetics.